Theoretical pharmacokinetic advantages and methodological flaws : glargine is not superior to NPH insulin in children with type 1 diabetes mellitus
dc.contributor.author | Dora, José Miguel Silva | pt_BR |
dc.contributor.author | Scheffel, Rafael Selbach | pt_BR |
dc.date.accessioned | 2012-05-03T01:26:17Z | pt_BR |
dc.date.issued | 2010 | pt_BR |
dc.identifier.issn | 0004-2730 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/40073 | pt_BR |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Arquivos brasileiros de endocrinologia & metabologia = Brazilian archives of endocrinology and metabolism. Vol. 54, n. 1 (fev. 2010), p. 82-84 | pt_BR |
dc.rights | Open Access | en |
dc.subject | Farmacocinética | pt_BR |
dc.subject | Insulina isofana | pt_BR |
dc.subject | Criança | pt_BR |
dc.subject | Métodos | pt_BR |
dc.subject | Complicações do diabetes | pt_BR |
dc.subject | Diabetes mellitus tipo 1 | pt_BR |
dc.title | Theoretical pharmacokinetic advantages and methodological flaws : glargine is not superior to NPH insulin in children with type 1 diabetes mellitus | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 000755443 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Files in this item
This item is licensed under a Creative Commons License
-
Journal Articles (39096)Health Sciences (10544)